Arcellx

Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership.

Arcellx has been a model Maryland growth company. Having started in the Germantown Innovation Center, Arcellx moved to West Watkins Mill and is now repositioning an office building in Rockville. Today, Arcellx is planning a manufacturing facility in Frederick County after evaluating sites in Maryland and California, the home of Arcellx’s CEO and CSO.